TY  - JOUR
AU  - Jia, Bo
AU  - Shi, Yuankai
AU  - Dong, Mei
AU  - Feng, Fengyi
AU  - Yang, Sheng
AU  - Lin, Hua
AU  - Zhou, Liqiang
AU  - Zhou, Shengyu
AU  - Chen, Shanshan
AU  - Yang, Jianliang
AU  - Liu, Peng
AU  - Qin, Yan
AU  - Zhang, Changgong
AU  - Gui, Lin
AU  - Wang, Lin
AU  - Wang, Xue
AU  - He, Xiaohui
PY  - 2014
TI  - Clinical features, survival and prognostic factors of primary testicular diffuse large B-cell lymphoma
JF  - Chinese Journal of Cancer Research; Vol 26, No 4 (August 20, 2014): Chinese Journal of Cancer Research
Y2  - 2014
KW  - 
N2  - Objective: To assess the clinical features, survival and prognostic factors of primary testicular diffuse large B-cell lymphoma (DLBCL).  Methods: A retrospective study of 37 patients with primary testicular DLBCL was carried out from November 2003 to May 2012. Their clinical features, survival and prognostic factors were analyzed.  Results: During a median follow-up period of 39.8 months (5.4-93.0 months), the median progression-free survival (PFS) was 26.2 months (95% CI: 0-65 months) and the 3-year overall survival (OS) rate was 78.4%. Within the whole cohort, the factors significantly associated with a superior PFS were limited stage (stage I/II), lactate dehydrogenase (LDH) ≤245 U/L, international prognostic index (IPI) ≤1, primary tumor diameter 
UR  - https://cjcr.amegroups.org/article/view/4358